AlphAIAlphAI — Financial news for AI agents
paulweiss.com

Aurora Cannabis to Be Acquired by Organigram

Aurora Cannabis Inc. will be acquired by Organigram Global Inc. for C$7.80 per share, valuing Aurora at C$561 million. The deal, expected to close in January 2027, creates a global cannabis company supported by British American Tobacco. Aurora's board rejected a hostile bid from Curaleaf Holdings.

Original reporting
paulweiss.com
Published Nov 4, 2026, 12:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 5:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMergers & acquisitions
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$OGI
Relevance
8/10
AlphAI data visualization · based on paulweiss.com
Decision brief

The 30-second read

Med
01

Why it matters

The acquisition combines Organigram's financial backing (including British American Tobacco) with Aurora's product portfolio, aiming for a leading global position.

02

Market read

The deal reshapes the competitive landscape of the global cannabis market and may affect related stocks and sector ETFs.

03

What to watch

Regulatory approvals and potential antitrust scrutiny could delay or derail the transaction.

Relevance 8/10Novelty 8/10Timing: post-announcement, deal closing expected Jan 2027

Background

Both companies are listed on the Toronto Stock Exchange and are among the largest Canadian cannabis producers.

Market effects

Sector

Consolidation in the cannabis sector may pressure other Canadian growers.

Regional

Strengthens Canadian cannabis presence in Europe and Australia.

Global

Creates a larger global player, potentially influencing international cannabis regulations.

Counterpoint

What could challenge this read

The cash premium may be insufficient, risking a prolonged integration and valuation drag.

Key entities

  • Strategic Shareholder
    British American Tobacco

    Cornerstone shareholder of Organigram, providing strategic support.

Read at source← All news

StoryOrganigram agrees to acquire Aurora in C$561 million cannabis deal

Also covered by

6 outlets

Related articles

$ACBHighAI 9/10

Edmonton's Aurora Cannabis agrees to sell to Organigram, eight years after the legalization boom

Organigram Global Inc. agreed to acquire Aurora Cannabis Inc. for approximately $561 million, outbidding a hostile offer from Curaleaf Holdings Inc. Aurora's CEO highlighted the strategic fit, combining Aurora's international medical cannabis strengths with Organigram's Canadian recreational market dominance. The deal offers Aurora shareholders $7.80 per share in cash, stock, or a mix, with cash capped at $253.6 million. Aurora's stock closed at $7.24 on the Toronto Stock Exchange.

edmontonjournal.com
HighAI 9/10

Aurora Cannabis Stock: What Organigram's Buyout Means for Investors

Aurora Cannabis (ACB) shares surged 22% after Organigram (OGI) agreed to acquire it for C$561M (~$400M). The deal offers C$7.80 per share, a 93% premium over ACB's unaffected price. The companies expect C$50M in annual cost synergies. The deal needs shareholder and regulatory approval, with closing expected in January 2027. Curaleaf's (CURLF) hostile bid remains outstanding.

zacks.com
HighAI 9/10

Organigram launches $561-million takeover offer for Aurora Cannabis

Organigram (OGI) has offered to acquire Aurora Cannabis (ACB) for $561 million, or $7.80 per share, a 21% premium over Curaleaf's (CURLF) offer. Aurora, once valued at $14 billion, has struggled with overpaying for acquisitions and declining market value. The deal requires approval from at least two-thirds of Aurora shareholders.

theglobeandmail.com